Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fujiki

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure]Yoshitaka Yamamura, Osamu Sato, Hiroyuki Fujiki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 27, 2006
[Vasopressin receptors]Toyoki Mori, Shigeki Nakamura, Hiroyuki Fujiki
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 19, 2013
Tolvaptan, an orally active non-peptide arginine vasopressin V2 receptor antagonist, reduces ascites in rats with chronic liver injuryToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura
The Journal of Endocrinology|April 16, 2010
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptanToshiki Miyazaki, Koji Ohmoto, Tsuyoshi Hirose, et al.
ACS Omega|June 1, 2026
Sweep Heating Thermal Conductivity Detector for 100 ppm Hydrogen Gas DetectionTakashi Harumoto, Jundong Song, Hiroyuki Fujiki, et al.
Cardiovascular Drugs and Therapy|November 29, 2011
Anti-edematous effects of tolvaptan in experimental rodent modelsToshiki Miyazaki, Yuki Sakamoto, Tatsuya Yamashita, et al.
Cardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.
Materials Horizons|September 13, 2023
Negative differential resistance based on phase transformationTakashi Harumoto, Hiroyuki Fujiki, Ji Shi, et al.
Japanese Journal of Pharmacology|February 22, 2002
Effect of oral OPC-28326, a selective femoral arterial vasodilator, on hindlimb subcutaneous tissue temperature in conscious dogs under buprenorphine sedationKensuke Orito, Takashi Imaizumi, Kenji Yoshida, et al.
Cardiovascular Drugs and Therapy|November 29, 2011
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failureToshiyuki Onogawa, Yuki Sakamoto, Shigeki Nakamura, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure]Yoshitaka Yamamura, Osamu Sato, Hiroyuki Fujiki
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 27, 2006
[Vasopressin receptors]Toyoki Mori, Shigeki Nakamura, Hiroyuki Fujiki
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 19, 2013
Tolvaptan, an orally active non-peptide arginine vasopressin V2 receptor antagonist, reduces ascites in rats with chronic liver injuryToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura
The Journal of Endocrinology|April 16, 2010
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptanToshiki Miyazaki, Koji Ohmoto, Tsuyoshi Hirose, et al.
ACS Omega|June 1, 2026
Sweep Heating Thermal Conductivity Detector for 100 ppm Hydrogen Gas DetectionTakashi Harumoto, Jundong Song, Hiroyuki Fujiki, et al.
Cardiovascular Drugs and Therapy|November 29, 2011
Anti-edematous effects of tolvaptan in experimental rodent modelsToshiki Miyazaki, Yuki Sakamoto, Tatsuya Yamashita, et al.
Cardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.
Materials Horizons|September 13, 2023
Negative differential resistance based on phase transformationTakashi Harumoto, Hiroyuki Fujiki, Ji Shi, et al.
Japanese Journal of Pharmacology|February 22, 2002
Effect of oral OPC-28326, a selective femoral arterial vasodilator, on hindlimb subcutaneous tissue temperature in conscious dogs under buprenorphine sedationKensuke Orito, Takashi Imaizumi, Kenji Yoshida, et al.
Cardiovascular Drugs and Therapy|November 29, 2011
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failureToshiyuki Onogawa, Yuki Sakamoto, Shigeki Nakamura, et al.
Pageof 3